6-Azaindole - CAS 271-29-4
Catalog: |
BB019472 |
Product Name: |
6-Azaindole |
CAS: |
271-29-4 |
Synonyms: |
1H-pyrrolo[2,3-c]pyridine; 1H-pyrrolo[2,3-c]pyridine |
IUPAC Name: | 1H-pyrrolo[2,3-c]pyridine |
Description: | 6-Azaindole (CAS# 271-29-4) is used as a reactant in the preparation of (spirocyclylamido)aminothiophene compounds and their proliferative activity for treatment of tumors and cancers. |
Molecular Weight: | 118.14 |
Molecular Formula: | C7H6N2 |
Canonical SMILES: | C1=CNC2=C1C=CN=C2 |
InChI: | InChI=1S/C7H6N2/c1-3-8-5-7-6(1)2-4-9-7/h1-5,9H |
InChI Key: | XLKDJOPOOHHZAN-UHFFFAOYSA-N |
Boiling Point: | 295.8 °C at 760 mmHg |
Density: | 1.242 g/cm3 |
MDL: | MFCD01686899 |
LogP: | 1.56290 |
GHS Hazard Statement: | H302 (95.74%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P330, P332+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-111740019-A | Halide perovskite photoelectric device based on polar interface | 20200605 |
WO-2021209765-A2 | Methods and products | 20200417 |
WO-2021203023-A1 | Indole derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (aatd) | 20200403 |
WO-2021202480-A1 | Compounds targeting prmt5 | 20200401 |
WO-2021169990-A1 | Kras inhibitors for treating cancers | 20200224 |
PMID | Publication Date | Title | Journal |
32077280 | 20200326 | Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133 | Journal of medicinal chemistry |
24937104 | 20140724 | GPR103 antagonists demonstrating anorexigenic activity in vivo: design and development of pyrrolo[2,3-c]pyridines that mimic the C-terminal Arg-Phe motif of QRFP26 | Journal of medicinal chemistry |
23206859 | 20130101 | Inhibitors of HIV-1 attachment. Part 11: the discovery and structure-activity relationships associated with 4,6-diazaindole cores | Bioorganic & medicinal chemistry letters |
22667999 | 20120615 | Synthesis of 2,5-disubstituted 6-azaindoles from substituted aziridines via intramolecular cyclization | Organic letters |
21840218 | 20110915 | Structure-based optimization of potent 4- and 6-azaindole-3-carboxamides as renin inhibitors | Bioorganic & medicinal chemistry letters |
Complexity: | 103 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 118.053098200 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 118.053098200 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 28.7 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Azaindoles
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS